This site is intended for healthcare professionals
Drug news

FDA provides complete response letter for Dsuvia (sufentanil sublingual tablet) in acute pain.- AcelRx Pharmaceuticals.

Read time: 1 mins
Last updated:13th Oct 2017
Published:13th Oct 2017
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest